Aging
Navigate
Submit an Article
Research Paper|Volume 11, Issue 22|pp. 10697–10710
MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis
Back to articleFigure 7(7 of 7)
100%
Figure 7
Figure 7.Co-expression of MAP2K4 and Vimentin is an unfavorable factor in breast cancer patient prognoses. (A–C) The log-rank test was used to calculate P-values.